The Global CEO Initiative on Alzheimer’s Disease Recommendations for Performance Standards and Test Characteristics for In-Clinic Digital Cognitive Assessments

As the prevalence of mild cognitive impairment and dementia continues to rise – and as evidence increasingly underscores the importance of earlier identification and intervention – health systems face mounting pressure to improve how cognitive concerns are recognized, assessed, and managed. Traditional paper-based assessments, while well established, are often constrained by time, workforce capacity, and limited sensitivity in early or atypical presentations, particularly in busy primary care and community settings.

DCAs offer the potential to provide more scalable, efficient, and standardized methods for assessing cognition across diverse populations and care environments. At the same time, available DCA tools vary widely in their design, intended use, validation, and performance. To address this gap, CEOi convened a multidisciplinary workgroup to establish recommendations on preferred test characteristics and minimum acceptable performance standards for clinic-based DCAs – helping define what “good” looks like as these tools move toward broader clinical adoption.